ATTIVA S.I.H. Technology is an electromedical device for capacitive and resistive diathermy for endodermal and exodermic treatments, manufactured by ITALIAN ENGINEERING S.r.l. and worldwide distributed by TEMA MEDICINA S.r.l.
ATTIVA S.I.H. Technology is a PATENTED subdermal induced heat technology based on the modulation of different current types: continuous, fractional and sequential. By uniformly heating the subdermal tissue layers with a powerful but controlled energy, ATTIVA allows a complete mastering of results with the highest precision. At first the soft tissue is contracted, then there is shrinkage of the collagen structure of the dermis which causes a stimulation of the fibroblast activity in reaction to the procedure’s trauma. This fibroblast activity stimulates the elastin production and the synthesis of new collagen.
Our technology is intended for physicians seeking for an efficient and safe solution to treat the signs of aging without surgery. ATTIVA S.I.H. Technology offers patients dramatic aesthetic enhancements to the quality of their skin with no downtime, no scarring and with immediate results. A new benchmark in the medical treatment of ageing loose skin.
We inform that the
attivarf.com and
temamedicina.com web site are related to our worldwide distributor (Tema Medicina S.r.l. company).
For more information contact our
worldwide distributor.
ATTIVA is a Radiofrequency (RF) System indicated:
In the United States ATTIVA Radiofrequency (RF) System (generator, electrodes/handpieces and accessories) is indicated for treatments based on the emission of electromagnetic waves (in continuous current mode only) that lead to a rise of internal temperature of tissues involved in the treatment for electrocoagulation and hemostasis. ATTIVA device can be used on adult patients only.
In Europe for medical therapy. The use of ATTIVA is based on the emission of electromagnetic waves that lead to a rise of internal temperature of tissues involved in the treatment. The produced hyperthermia both in Esodermic and Endodermic mode, fosters vasodilation and consequent increase of cell oxygenation and biostimulation of cellular components.
Important: the use of esodermic handpieces and “Gynè” gynecological handpiece is certified and granted only for the European territory and not for the US and Iranian territory.
Important Safety Considerations: ATTIVA System should not be used on patients who are pregnant, have a fever or skin infection in or around the area of treatment. Expected procedure side effects may include transient pain in the procedure area, erythema and edema. Individual results may vary.
